CEOs Love Reshoring Announcements. Their Capex Budgets Do Not.

There is a particular species of CEO earnings call performance that deserves its own taxonomic classification. It occurs during prepared remarks, usually in the second or third quarter when geopolitical anxiety has been simmering long enough to warrant a strategic pivot. The executive leans into the microphone with the solemnity of someone announcing a moonshot. "We are repatriating critical manufacturing," he says. "Friend-shoring our supply chains. Building resilience into our cost structure." The analyst community nods approvingly. A press release lands. CNBC runs the headline. The stock ticks up 1.2%. By the following quarter, the reshoring narrative has quietly evaporated, replaced by commentary on margin compression and the unexpected durability of Vietnamese suppliers.

This is not cynicism. This is capital allocation watching you in the eye and lying.

The reshoring theatre of 2023 and 2024 has been one of corporate America's most durable political performances. Executives have announced roughly $200 billion in "US manufacturing commitment" since the Inflation Reduction Act's passage in August 2022. The optics are pristine. Patriotic. They land well at a certain kind of stakeholder dinner. But the actual capex being deployed tells a significantly different story: modest, incremental capacity additions justified primarily as geopolitical hedging—not wholesale supply chain reconstruction.

Consider the data. Manufacturing capex as a percentage of revenue across the Fortune 500 has barely budged since 2019, hovering around 3.2 to 3.5 percent. If reshoring were the structural priority executives claim during earnings calls, you would expect to see a measurable inflection. Instead, capex discipline remains intact. The announced $200 billion commitment? Spread across seven to ten years. Roughly $20 billion annually—which, when distributed across the companies making the announcements, translates to margin-of-error increases in capital intensity.

Meanwhile, Vietnam and India continue to capture supply chain share. Vietnamese manufacturing exports have grown 18 percent year-over-year through 2024, while semiconductor and electronics components destined for India have accelerated. These are not countries whose supply chains are becoming less relevant to the boards pretending to reshore. They are becoming more embedded in the architecture of global manufacturing, even as press releases celebrate American factory reopenings.

The real diagnosis emerges from board risk committee minutes—the unsexy, candid documents where executives stop performing. Geopolitical risk is being treated as cyclical volatility, not structural threat. This changes everything about capital allocation. A cyclical risk warrants hedging: locating modest backup capacity in friendly jurisdictions to protect against tariffs or supply disruption. A structural risk warrants restructuring: the wholesale relocation of production footprints at extraordinary capex cost. Boards have clearly decided on the former.

This distinction explains the tariff pass-through margins. Companies made announcements about reshoring to "protect margins from tariff exposure." What happened instead? Tariff pass-through actually narrowed. Customers resisted price increases. Competitors refused to cede margin. The reshored capacity, where it materialized, became a marginal cost option for peak demand—not the primary manufacturing location. Vietnam remained the baseline. The US facility became the safety valve.

The forensic question is not whether executives are lying. They are not, technically. They are hedging. They are adding capacity. They are friend-shoring, in the sense that they are diversifying away from China. But they are doing so with the minimum capex required to satisfy multiple audiences: the politicians who passed the IRA, the activist investors who care about ESG and stakeholder resilience, the analysts who track capex efficiency, and the customers who reward companies that do not blow up their margin structure on geopolitical theater.

It is actually a marvel of equilibrium. Everyone gets something. The optics are satisfied. The capital discipline is preserved. The Vietnam facilities keep humming. The stock price benefits from the headline and avoids the penalty of massive capex deployment.

The only constituency not fully represented in this equation is the one reading earnings call transcripts and wondering whether supply chain resilience is actually being built or merely announced. The capex data suggests the answer. Press releases, by contrast, suggest something altogether different. Both are true. That gap between announcement and action is where the real business is getting done.